Aberrant NKG2D expression with IL-17 production of CD4+ T subsets in patients with type 2 diabetes

Immunobiology

Volumn 222, Issue 10, 2017, Pages 944-951

  Phoksawat, Wisitsak ^a   Jumnainsong, Amonrat ^a   Leelayuwat, Naruemon ^a   Leelayuwat, Chanvit ^a  

^a KHON KAEN UNIVERSITY   (Thailand)

Author keywords

CD4 + CD28null T subset; IL 17; NKG2D; Type 2 diabetes

Indexed keywords

HEMOGLOBIN A1C; INTERLEUKIN 17; MONOCLONAL ANTIBODY; NATURAL KILLER CELL RECEPTOR NKG2D; NATURAL KILLER CELL RECEPTOR NKG2D ANTIBODY; PHORBOL 13 ACETATE 12 MYRISTATE; T LYMPHOCYTE RECEPTOR; UNCLASSIFIED DRUG; GLYCOSYLATED HEMOGLOBIN; KLRK1 PROTEIN, HUMAN; LYMPHOCYTE ANTIGEN RECEPTOR; NATURAL KILLER CELL LECTIN LIKE RECEPTOR SUBFAMILY K;

ADULT; ARTICLE; CD4+ T LYMPHOCYTE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; FLOW CYTOMETRY; GLYCEMIC CONTROL; HUMAN; HUMAN CELL; LYMPHOCYTE ACTIVATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; CELL CULTURE; CELL PROLIFERATION; GENE EXPRESSION; GENETICS; HYPOGLYCEMIA; IMMUNOLOGY; IMMUNOPHENOTYPING; METABOLISM; MIDDLE AGED;

ADULT; ANTIBODIES, MONOCLONAL; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; DIABETES MELLITUS, TYPE 2; FEMALE; GENE EXPRESSION; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIA; IMMUNOPHENOTYPING; INTERLEUKIN-17; LYMPHOCYTE ACTIVATION; MALE; MIDDLE AGED; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY K; RECEPTORS, ANTIGEN, T-CELL;

EID: 84975117239     PISSN: 01712985     EISSN: 18783279     Source Type: Journal    
DOI: 10.1016/j.imbio.2016.05.001     Document Type: Article

References (38)

1. Abbas, A.K., Murphy, K.M., Sher, A., Functional diversity of helper T lymphocytes. Nature 383 (1996), 787–793.
2. Alonso-Arias, R., Moro-Garcia, M.A., Lopez-Vazquez, A., Rodrigo, L., Baltar, J., Garcia, F.M., Jaurrieta, J.J., Lopez-Larrea, C., NKG2D expression in CD4+ T lymphocytes as a marker of senescence in the aged immune system. Age (Dordr) 33 (2011), 591–605.
3. American Diabetes Association, Diagnosis and classification of diabetes mellitus. Diabetes Care 37:1 (2014), S81–S90.
4. American Diabetes Association, Standards of medical care in diabetes-2015. Diabetes Care 38:1 (2015), S33–S40.
5. − T cells in immune disorders. Trends Mol. Med. 18 (2012), 446–453.
6. Burgess, S.J., Maasho, K., Masilamani, M., Narayanan, S., Borrego, F., Coligan, J.E., The NKG2D receptor: immunobiology and clinical implications. Immunol. Res. 40 (2008), 18–34.
7. Chanchamroen, S., Kewcharoenwong, C., Susaengrat, W., Ato, M., Lertmemongkolchai, G., Human polymorphonuclear neutrophil responses to Burkholderia pseudomallei in healthy and diabetic subjects. Infect. Immun. 77 (2009), 456–463.
8. Chen, F.Q., Wang, J., Liu, X.B., Ma, X.Y., Zhang, X.B., Huang, T., Ma, D.W., Wang, Q.Y., Levels of inflammatory cytokines in type 2 diabetes patients with different urinary albumin excretion rates and their correlation with clinical variables. J. Diabetes Res., 2013, 10.1155/2013/138969.
9. Dejaco, C., Duftner, C., Al-Massad, J., Wagner, A.D., Park, J.K., Fessler, J., Aigelsreiter, A., Hafner, F., Vega, S., Sterlacci, W., Grubeck-Loebenstein, B., Tzankov, A., Ness, T., Boiardi, L., Salvarani, C., Schirmer, M., NKG2D stimulated T-cell autoreactivity in giant cell arteritis and polymyalgia rheumatica. Ann. Rheum. Dis. 72 (2013), 1852–1859.
10. Dekker, L.V., Parker, P.J., Protein kinase C-a question of specificity. Trends Biochem. Sci. 19 (1994), 73–77.
11. Donath, M.Y., Shoelson, S.E., Type 2 diabetes as an inflammatory disease. Nat. Rev. Immunol. 11 (2011), 98–107.
12. null T cells in coronary artery disease: when helpers become killers. Cardiovasc. Res. 81 (2009), 11–19.
13. Duncan, B.B., Schmidt, M.I., Pankow, J.S., Ballantyne, C.M., Couper, D., Vigo, A., Hoogeveen, R., Folsom, A.R., Heiss, G., Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52 (2003), 1799–1805.
14. Faruqi, T.R., Gomez, D., Bustelo, X.R., Bar-Sagi, D., Reich, N.C., Rac1 mediates STAT3 activation by autocrine IL-6. Proc. Natl. Acad. Sci. U. S. A. 98 (2001), 9014–9019.
15. Fiocco, U., Accordi, B., Martini, V., Oliviero, F., Facco, M., Cabrelle, A., Piva, L., Molena, B., Caso, F., Costa, L., Scanu, A., Pagnin, E., Atteno, M., Scarpa, R., Basso, G., Semenzato, G., Punzi, L., Doria, A., Dayer, J.M., JAK/STAT/PKCdelta molecular pathways in synovial fluid T lymphocytes reflect the in vivo T helper-17 expansion in psoriatic arthritis. Immunol. Res. 58 (2014), 61–69.
16. Ginter, E., Simko, V., Global prevalence and future of diabetes mellitus. Adv. Exp. Med. Biol. 771 (2012), 35–41.
17. null T-lymphocytes in diabetic patients: exploring new pathogenetic mechanisms of increased cardiovascular risk in diabetes mellitus. Eur. Heart J. 32 (2011), 1214–1226.
18. Groh, V., Bruhl, A., El-Gabalawy, H., Nelson, J.L., Spies, T., Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. U. S. A. 100 (2003), 9452–9457.
19. Groop, L., Pociot, F., Genetics of diabetes-are we missing the genes or the disease?. Mol. Cell. Endocrinol. 382 (2014), 726–739.
20. International Diabetes Federation, IDF Diabetes Atlas. 7th ed., 2015, Brussels, Belgium.
21. Iqbal, N., Rubenstein, A.H., Does lowering of blood glucose improve cardiovascular morbidity and mortality?. Clin. J. Am. Soc. Nephrol. 3 (2008), 163–167.
22. Jagannathan-Bogdan, M., McDonnell, M.E., Shin, H., Rehman, Q., Hasturk, H., Apovian, C.M., Nikolajczyk, B.S., Elevated proinflammatory cytokine production by a skewed T cell compartment requires monocytes and promotes inflammation in type 2 diabetes. J. Immunol. 186 (2011), 1162–1172.
23. Jain, N., Zhang, T., Kee, W.H., Li, W., Cao, X., Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J. Biol. Chem. 274 (1999), 24392–24400.
24. King, D.E., Mainous, A.G. 3rd, Buchanan, T.A., Pearson, W.S., C-reactive protein and glycemic control in adults with diabetes. Diabetes Care 26 (2003), 1535–1539.
25. Lopez-Larrea, C., Suarez-Alvarez, B., Lopez-Soto, A., Lopez-Vazquez, A., Gonzalez, S., The NKG2D receptor: sensing stressed cells. Trends Mol. Med. 14 (2008), 179–189.
26. Ma, R.C., Chan, J.C., Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Ann. N. Y. Acad. Sci. 1281 (2013), 64–91.
27. − T cells revisited: solved or still ongoing?. J. Immunol. Res., 2015, 10.1155/2015/348746.
28. + T cells of patients with Crohn's disease. Gastroenterology 141 (2011), 217–226.
29. Pedicino, D., Liuzzo, G., Trotta, F., Giglio, A.F., Giubilato, S., Martini, F., Zaccardi, F., Scavone, G., Previtero, M., Massaro, G., Cialdella, P., Cardillo, M.T., Pitocco, D., Ghirlanda, G., Crea, F., Adaptive immunity, inflammation, and cardiovascular complications in type 1 and type 2 diabetes mellitus. J. Diabetes Res., 2013, 10.1155/2013/184258.
30. Rocha, V.Z., Libby, P., Obesity, inflammation, and atherosclerosis. Nat. Rev. Cardiol. 6 (2009), 399–409.
31. + T cells specific for human cytomegalovirus. Eur. J. Immunol. 36 (2006), 3198–3206.
32. Sumarac-Dumanovic, M., Jeremic, D., Pantovic, A., Janjetovic, K., Stamenkovic-Pejkovic, D., Cvijovic, G., Stevanovic, D., Micic, D., Trajkovic, V., Therapeutic improvement of glucoregulation in newly diagnosed type 2 diabetes patients is associated with a reduction of IL-17 levels. Immunobiology 218 (2013), 1113–1118.
33. Tan, S.L., Zhao, J., Bi, C., Chen, X.C., Hepburn, D.L., Wang, J., Sedgwick, J.D., Chintalacharuvu, S.R., Na, S., Resistance to experimental autoimmune encephalomyelitis and impaired IL-17 production in protein kinase C theta-deficient mice. J. Immunol. 176 (2006), 2872–2879.
34. Upshaw, J.L., Leibson, P.J., NKG2D-mediated activation of cytotoxic lymphocytes: unique signaling pathways and distinct functional outcomes. Semin. Immunol. 18 (2006), 167–175.
35. Vivier, E., Ugolini, S., Nunes, J.A., ADAPted secretion of cytokines in NK cells. Nat. Immunol. 14 (2013), 1108–1110.
36. Yang, X.P., Ghoreschi, K., Steward-Tharp, S.M., Rodriguez-Canales, J., Zhu, J., Grainger, J.R., Hirahara, K., Sun, H.W., Wei, L., Vahedi, G., Kanno, Y., O'Shea, J.J., Laurence, A., Opposing regulation of the locus encoding IL-17 through direct, reciprocal actions of STAT3 and STAT5. Nat. Immunol. 12 (2011), 247–254.
37. Ye, J., Mechanisms of insulin resistance in obesity. Front. Med. 7 (2013), 14–24.
38. Zeng, C., Shi, X., Zhang, B., Liu, H., Zhang, L., Ding, W., Zhao, Y., The imbalance of Th17/Th1/Tregs in patients with type 2 diabetes: relationship with metabolic factors and complications. J. Mol. Med. (Berl.) 90 (2012), 175–186.